Since 1980, many species and different strains from endophytic genera of Phomopsis, Fusarium, Pestaliopsis and Aspergillus have been studied because of their ability to produce medicinal compounds found in their host plants. Some of these medicinal agents such as Taxol, Brefeldine A, Camptothecine and Podophyllotoxin are being produced in large-scale after an optimization process. However, the potential of fungal endophyes to produce host-like medicinal compounds remains largely unexplored.